11/13/2024
4:16 PM | Matinas Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
5:31 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
8:15 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Matinas Biopharma (Subject)
| Form SC 13G | |
09/03/2024
7:56 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
8:39 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:06 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
6:00 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/04/2024
3:15 PM | Matinas Biopharma (Filer)
| Form 424B5 | |
03/28/2024
8:00 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
3:22 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
3:22 PM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
7:05 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
8:20 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
5:35 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
7:05 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
6:35 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:30 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
6:40 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
6:40 AM | Matinas Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
8:46 PM | Jabbour Jerome D (Reporting)
Matinas Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
8:46 PM | Liu Hui (Reporting)
Matinas Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
8:46 PM | Kucinski Keith A (Reporting)
Matinas Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
8:46 PM | Hoover Thomas (Reporting)
Matinas Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
8:46 PM | Matinas Biopharma (Issuer)
Matkovits Theresa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
8:46 PM | Ferguson James J. III (Reporting)
Matinas Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free MTNB Stock Alerts